StoreGene - Comprehensive Cardiovascular Package
Storegene unlocks the power of genomics for health care. Storegene TARGeTs (Translational Automated Rapid Genomic Tests) analyze whole genome data and apply generative AI to deliver actionable insights for individual health plans. Originated from the renowned UCL (University College London) research team, serving the UK's top health providers, StoreGene's affordable, accessible, actionable genomics delivers advanced precision medicine today.
About
StoreGene offers the most comprehensive cardiovascular genetics package on the market today, bridging the gap between genetics and cardiovascular care, and offering clinicians a powerful tool to provide personalized treatment for their patients. This package represents a significant advancement in cardiovascular medicine, giving patients the knowledge and support they need to take charge of their heart health.
This package contains 4 tests in one, including the most up-to-date Familial Hypercholesterolaemia (FH) panel, the MetaGRS assessment which looks at 1.7 million variants in your genome to determine your 10 year likelihood of developing cardiovascular disease, an extensive Lipoprotein(a) polygenic risk score, and a pharmacogenomic (PGx) heart medication response to determine your metabolising status for a number of heart medicines including statins, warfarin and clopidogrel.
Clinicians are equipped with actionable information to create tailored treatment plans. These plans are based on a patient’s genetic profile, enabling more precise medication selection, lifestyle recommendations, and monitoring strategies
